Jump to content

Covid-19 #25: The Prisoner’s Dilemma


Fragile Bird

Recommended Posts

The state of CT just announced the next tiers for vaccine eligibility.  After teachers and child care workers, they’re just jumping into age tranches.  55+ are eligible now, then 45+ are eligible from March 22nd.  I’ll be eligible in mid April, not that there’s any guarantee that there will be vaccine supply and appointments available.

The grocery store workers are pretty pissed off that they weren’t given priority as frontline/essential workers before the eligibility devolved to just age brackets.  They’re absolutely right.  I know Lamont is saying simple is better and it’s hard to enforce many criteria, but that’s no way to treat people who’ve shown up work in risky environments all this time.  

Link to comment
Share on other sites

If today's testimony can be relied upon, Pfizer and Moderna are projecting huge production increases over the next 5 weeks that will result in 140 million more doses in the US. They sound confident, but I'll believe it when the shot goes in my arm....Biden administration is predicting that about 200 million doses distributed by the end of March (that's a cumulative number including Dec-Mar). 

That said, sounds like the big bottleneck is at the fill/finish level.  So what we really need is more putting vaccines in bottles to ship out.  Also sounds like J&J will have significantly more availability in April, assuming there is a positive recommendation Friday and approval over the weekend. There are very few doses now, but they say 60 million by the end of April.  If that holds, then I would think by the second or third week of May we would be looking at a very large number of fully vaccinated people in the US.  

 

 

Link to comment
Share on other sites

13 minutes ago, Mlle. Zabzie said:

No more than you were the moment before and the moment after?

We were walking towards each other in a standard hospital hallway. For whatever reason she randomly started to veer towards me.

Link to comment
Share on other sites

3 hours ago, Clueless Northman said:

And when it comes to producing vaccines, this shit is turning into a sad sick joke, truly: EXCLUSIVE-AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official | Reuters

There is some confusion on this issue (seems i'm always conflating confusion with AZ).  AstraZeneca is now saying that it will deliver the expected amount in Q2 but that half will come from its international supply network (and half from its EU network).  I wonder what that means.  Does some other country lose out?  COVAX is a big recipient of AZ supplies.

Astrazeneca-says-it-will-deliver-all-contracted-second-quarter-vaccines-to-EU

But yes, you certainly would prefer if other suppliers were emerging given the consistent issues.  I don't think Sputnik will be the saviour though.  They still haven't applied.  For weeks they were insisting that they already had, despite the EU saying "nope".  I fear they have no idea what an EU application requires.  And people don't think they have the capacity to deliver significant volumes to the EU.  Far easier to supply a few smaller countries.

I don't think we'll see anything substantial delivered from J&J until April, even if/when it gets approved in March..  (Sanofi announced today that it was going to produce vaccines for J&J but not until Q3.  I presume J&J's own factories will lead things in Q2.  I'm wonder was Macron making calls.  After all the delivery issues in January, this is the second collaboration that Sanofi have announced.  A couple weeks ago it was Pfizer.  The EU has ordered 300m Sanofi vaccines but they are embarrassingly way off having their own vaccine approved.  I can see this as one way for it to quietly rebuild bridges).

Moderna and Pfizer are ramping up deliveries in the EU but I don't know are they to the kind of levels been reported by Mlle Zabzie for the US.  At the same time, deliveries in Ireland are supposed to go from 80k a week (right now) to 250k a week in April.   So maybe it is similar.

We have been told today, of the vaccines already administered in Ireland, 311,741 were the Pfizer-BioNTech vaccine, 33,634 were AstraZeneca and 4,947 were Moderna.  The Moderna number was shocking to me.  I was wondering did some EU countries swap orders? We'll take your Pfizer, you take Moderna?  Might be easier to deal with fewer types and they are practically identical efficacy wise.

Link to comment
Share on other sites

Since other AZ production locations are basically India and US and these countries seem keen on keeping a lot of that production for their own big vaccine needs, I wouldn't trust AZ guarantees at all.

At this point, the EU should really shift to ask and pressure to make the vaccines public and lift the patents. Heck, as we see with collaborations with Sanofi and others, even then it'll take months to have the production lines ready. EU should've joined other countries in 2020 to make this a precondition - but these idiots were all about how International properties are oh so important, as if tens of thousands of human lives (even more, tens of thousands of human lives of their own fellow European citizens) were worthless by comparison.

Link to comment
Share on other sites

7 hours ago, Padraig said:

Moderna and Pfizer are ramping up deliveries in the EU but I don't know are they to the kind of levels been reported by Mlle Zabzie for the US.  At the same time, deliveries in Ireland are supposed to go from 80k a week (right now) to 250k a week in April.   So maybe it is similar.

We have been told today, of the vaccines already administered in Ireland, 311,741 were the Pfizer-BioNTech vaccine, 33,634 were AstraZeneca and 4,947 were Moderna.  The Moderna number was shocking to me.  I was wondering did some EU countries swap orders? We'll take your Pfizer, you take Moderna?  Might be easier to deal with fewer types and they are practically identical efficacy wise.

Our delieveries are about to go up in the same order (got delivered until now 8 mio altogether, is forecast to be 18,5 mio end of March). Since we always get 19% of the EU deliveries (as this is proportional to population) I would think EU deliveries in March will be about 50 mio. Thats better, but really not good enough for 450 mio people. I do not have the exact moderna number but it wasnt that much here either I think about 150000 altogether until now. Actually I was wondering why we get Moderna at all? Isnt that a US company with US factories which should be forbidden to export? Not that I am complaining.

Link to comment
Share on other sites

12 minutes ago, Clueless Northman said:

At this point, the EU should really shift to ask and pressure to make the vaccines public and lift the patents. Heck, as we see with collaborations with Sanofi and others, even then it'll take months to have the production lines ready. EU should've joined other countries in 2020 to make this a precondition - but these idiots were all about how International properties are oh so important, as if tens of thousands of human lives (even more, tens of thousands of human lives of their own fellow European citizens) were worthless by comparison.

No, that is a too simple view. It just isnt possible to ramp up production for so many people that quickly. Israels success is great, but is has 9 mio citizens, so with the right prize (and it seems they pay a lot more per dose than the EU), they can get a large amount (in realtion to population)  delivered quickly. there is no incentive in the world that would have made it possible for the companies to get as many doses for the EU that quickly which has 450 mio people and not 9 mio. It just takes more time and has nothing to do with lifting patents, they are producing as good as they can.

That does not mean that the EU countries shouldnt help which production lines now (or actually starting last summer), but all I hear they do. Actually I read somewhere that they met last summer to discuss the quickest way to supply everyone - since a lot of the potential candidates were new technology and hard to produce, and decided to order AZ - because thats just more simple to do and here the production lines will be safe and stable...

Link to comment
Share on other sites

4 minutes ago, JoannaL said:

Actually I read somewhere that they met last summer to discuss the quickest way to supply everyone - since a lot of the potential candidates were new technology and hard to produce, and decided to order AZ - because thats just more simple to do and here the production lines will be safe and stable...

...another reason for also ordering AZ was that it would be an European supply line so not dependend on the US and their export limits and so certainly able to deliever to the EU without having to prefer other customers...

Actually it is  quite funny really,  if we would not talk about people dying daily because of their shortcomings...

 

 

Link to comment
Share on other sites

8 hours ago, Padraig said:

There is some confusion on this issue (seems i'm always conflating confusion with AZ).  AstraZeneca is now saying that it will deliver the expected amount in Q2 but that half will come from its international supply network (and half from its EU network).  I wonder what that means.  Does some other country lose out? 

Canada maybe?

as well as any possibility of EU vaccine diplomacy.

8 hours ago, Padraig said:

COVAX is a big recipient of AZ supplies.

With India blocking exports, AZ european problems and other suppliers far behind the lines, ti's likely that COVAX is at the verge of collapse, despite all the money poured into it.

Link to comment
Share on other sites

1 hour ago, JoannaL said:

decided to order AZ - because thats just more simple to do and here the production lines will be safe and stable...

Apparently, they're not - as you noted.

1 hour ago, JoannaL said:

 there is no incentive in the world that would have made it possible for the companies to get as many doses for the EU that quickly which has 450 mio people and not 9 mio. It just takes more time and has nothing to do with lifting patents, they are producing as good as they can.

With their mindset, we would've lost WW II, and very badly.

Plenty of grandstanding pols, including the Trumpster, said this was the greatest crisis since 1945, that it was akin to fighting a war and other claims. Well, turns out they still acted as if it was a nothing-burger. Were they serious about the war comparison, then they would've turned the society into a war economy with war emergency powers over private companies. They shouldn't have asked nicely in 2020 if pharma would like to produce vaccines, it should've been an order with specific targets, stressing that failure isn't an option, shifting entire parts of the manufacturing capacities of European countries towards vaccine production. They failed utterly because they are useless pols without any idea willpower, totally blinded by their neo-liberal ideology that "private business Good", shouldn't be limited or forced (or taxed!) in any way. This sick ideology has now been proven once again to be an abject failure and a murderous one.

Link to comment
Share on other sites

2 hours ago, JoannaL said:

 Actually I was wondering why we get Moderna at all? Isnt that a US company with US factories which should be forbidden to export? Not that I am complaining.

Moderna has an agreement with Lonza, a Swiss company to produce the vaccine for the European market.  And I think there are Spanish and French companies involved in the supply chain also.   I wonder are they still ramping up and that's why there is a big increase in total numbers expected in April?  The EU has ordered 310m doses for delivery this year, so they have to start arriving eventually!  And an option for another 150m next year.

If the Moderna numbers in Ireland reflect EU numbers, we really are almost completely reliant on Pfizer/Biontech right now.

2 hours ago, Clueless Northman said:

Since other AZ production locations are basically India and US and these countries seem keen on keeping a lot of that production for their own big vaccine needs, I wouldn't trust AZ guarantees at all.

At this point, the EU should really shift to ask and pressure to make the vaccines public and lift the patents. Heck, as we see with collaborations with Sanofi and others, even then it'll take months to have the production lines ready. EU should've joined other countries in 2020 to make this a precondition - but these idiots were all about how International properties are oh so important, as if tens of thousands of human lives (even more, tens of thousands of human lives of their own fellow European citizens) were worthless by comparison.

I thought there would be clarification stories about AZ this morning but there isn't.  Hmm.  Right to be wary.  And yes, I do wonder did the EU overly trust the pharma companies.  Especially as most of them were relatively small and had no history of generating the scale required.  Pfizer is doing best but its also, by far, the biggest manufacturer.  Joanna is right that the sheer size of the EU would always mean this was a long process but the US has administered twice the volumes that the EU has.  Hindsight is great but those kind of deals that Sanofi are signing could have been done months ago (or they have been working on them for the last 8 months.  They were that complicated!).

2 hours ago, JoannaL said:

...another reason for also ordering AZ was that it would be an European supply line so not dependend on the US and their export limits and so certainly able to deliever to the EU without having to prefer other customers...

Yes.  I remember reading how AZ was likely to be the best option last August (or so).  Tried and tested technology.  No strange mRNA tech.  A British/Swedish company etc.

1 hour ago, rotting sea cow said:

With India blocking exports, AZ european problems and other suppliers far behind the lines, ti's likely that COVAX is at the verge of collapse, despite all the money poured into it.

The first deliveries happened today.

https://www.bbc.com/news/world-africa-56180161

But you are right to keep an open mind.  I don't think India would ever stop all deliveries.  That would be self-destructive but it could certainly delay the speed of deliveries.  There is a Korean factory involved also but I don't know whether that facility is ready.

Link to comment
Share on other sites

As far as I know, AZ has plants manufacturing vaccine in many places all over the world. Japan will get 90 M doses from a plant in Japan, Australia will be supplied from a plant in Australia, a Chinese plant was expanded and production will be doubled from 100 M to 200 M doses, and there’s India and Korea.

It seems like the only place they refused to manufacture was in Canada. The government asked them to and they refused.

Link to comment
Share on other sites

39 minutes ago, Padraig said:

 Hindsight is great but those kind of deals that Sanofi are signing could have been done months ago (or they have been working on them for the last 8 months.  They were that complicated!).

Sanofi were trying to make their own vaccine until recently. It's only an option now because they've decided it isn't going to work in the time frame needed.

41 minutes ago, Padraig said:

Yes.  I remember reading how AZ was likely to be the best option last August (or so).  Tried and tested technology.  No strange mRNA tech.  A British/Swedish company etc.

It's tried and tested in the sense that a few adenovirus vaccines have been developed before but I don't think any of them have been mass produced yet. I think the mRNA vaccines were the first of their kind in any sense so there there was probably a bit more concern that it wouldn't work at all.

Link to comment
Share on other sites

Moderna has production sites in Belgium, Spain and Switzerland, I think, all part of the big assembly line, basically. I don't think any site can produce the whole product on its own, which is a shame, but I suppose it would mean downsizing production for months if they wanted to fix it. So, Europe is where most of EU vaccines will be made, I don't think there will be much imports from the US or India in their case.

 

2 minutes ago, ljkeane said:

Sanofi were trying to make their own vaccine until recently. It's only an option now because they've decided it isn't going to work in the time frame needed.

Yup, but plenty of big names have just entirely stopped researching and producing vaccines. Switzerland is supposed to be big in pharma, but they sold or outsourced their entire vaccine R/D. Yet they still should be able to produce components, if not whole vaccines, if they were told to.

Link to comment
Share on other sites

1 hour ago, Clueless Northman said:

 They shouldn't have asked nicely in 2020 if pharma would like to produce vaccines, it should've been an order with specific targets, stressing that failure isn't an option, shifting entire parts of the manufacturing capacities of European countries towards vaccine production. They failed utterly because they are useless pols without any idea willpower, totally blinded by their neo-liberal ideology that "private business Good", shouldn't be limited or forced (or taxed!) in any way. This sick ideology has now been proven once again to be an abject failure and a murderous one.

So the contracts with AZ show specific targets, doesnt help much...

About (state-induced) shifting of capacities to vaccine production:

That only works for EU (patents) -vaccines and it is done. - Really, to trust multinational non (or only part) -EU companies like AstraZeneca (bristish -swedish) was misguided.

Problem: the first EU vaccine on the market was Biontech and it is a very small company. there is hope that with Curevac and later with Sanofi there will be more purely EU vaccines on the market.

What is done? ( I only know for Germany, but I guess other EU countries act similar):

Biontech (data form the Biontech/Pfizer vaccine came in in November- and Pfizer could start producing immediately because it is a big company) got a factory for extra great conditions from the state of Hessia (and an unbelievable quick goverment approval for starting the production), and was able to set up everything  beginning of February (remember, new technology), they will start delivering in April. they also got an immediate contract with the Sanofi factories in Frankfurt for fill-up. In my opinion such a fast agreement with a competitor can only be done with some pushing by politicians.

Curevac is still smaller and we are waiting for the results of phase III. But already after some talks with politicians in Germany , miracolously, Bayer decided to remodel and set up their factory in Wuppertal to produce this vaccine (- before the results are in).

so I think there is  pushing by politicians - and this will be the same in other EU countries, it just doesnt lead to immediate results , because the first vaccines on the market were not EU (but of Biontech but I discussed that). But with Biontech and hopefully soon Curevac the EU will have  production capacity for  two of the new mRNA vaccines which can be easily adapted to new mutations and so on the long run this may turn out well (doesnt help in first half of 2021, but after that, the pandemic isnt over)

 

 

 

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

Guest
This topic is now closed to further replies.
×
×
  • Create New...